Hexapeptides that interfere with HIV-1 fusion peptide activity in liposomes block GP41-mediated membrane fusion

被引:13
作者
Gomara, Maria J.
Lorizate, Maier
Huarte, Nerea
Mingarro, Ismael
Perez-Paya, Enrique
Nieva, Jose L.
机构
[1] Univ Basque Country, EHU, CSIC, Biofis Unit, E-48080 Bilbao, Spain
[2] Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Burjassot, Valencia, Spain
[3] Ctr Invest Principe Felipe, E-46013 Valencia, Spain
[4] CSIC, E-46013 Valencia, Spain
来源
FEBS LETTERS | 2006年 / 580卷 / 11期
关键词
membrane fusion; viral fusion; gp41; HIV-1; fusion peptide; fusion inhibitor;
D O I
10.1016/j.febslet.2006.04.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Upon receptor-mediated activation, the gp41 hydrophobic, conserved fusion peptide inserts into the target membrane and promotes the kind of perturbations required for the progression of the HIV-cell fusion reaction. Using a synthetic combinatorial library we have identified all D-amino acid hexapeptide sequences that inhibited the fusion peptide capacity of perturbing model membranes. Two hexapeptides that effectively inhibited the fusion peptide in these systems were subsequently shown to inhibit cell-cell fusion promoted by gp41 expressed at cell surfaces. These observations might be of importance for understanding the mechanisms underlying fusion peptide activity and suggest new strategies for screening compounds that target these viral sequences. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2561 / 2566
页数:6
相关论文
共 43 条
[31]   OLIGOPEPTIDE INHIBITORS OF HIV-INDUCED SYNCYTIUM FORMATION [J].
OWENS, RJ ;
TANNER, CC ;
MULLIGAN, MJ ;
SRINIVAS, RV ;
COMPANS, RW .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (11) :1289-1296
[32]   Design of bioactive and structurally well-defined peptides from conformationally restricted libraries [J].
Pastor, MT ;
Mora, P ;
Ferrer-Montiel, A ;
Pérez-Payá, E .
BIOPOLYMERS, 2004, 76 (04) :357-365
[33]   Membrane fusion induced by the HIV type 1 fusion peptide: Modulation by factors affecting glycoprotein 41 activity and potential anti-HIV compounds [J].
Pereira, FB ;
Goni, FM ;
Nieva, JL .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (14) :1203-1211
[34]   LIPOSOME DESTABILIZATION INDUCED BY THE HIV-1 FUSION PEPTIDE EFFECT OF A SINGLE AMINO-ACID SUBSTITUTION [J].
PEREIRA, FB ;
GONI, FM ;
NIEVA, JL .
FEBS LETTERS, 1995, 362 (02) :243-246
[35]  
PINILLA C, 1992, BIOTECHNIQUES, V13, P901
[36]   PHOSPHOLIPID INTERACTIONS OF SYNTHETIC PEPTIDES REPRESENTING THE N-TERMINUS OF HIV GP41 [J].
RAFALSKI, M ;
LEAR, JD ;
DEGRADO, WF .
BIOCHEMISTRY, 1990, 29 (34) :7917-7922
[37]   MEMBRANE-FUSION ACTIVITY OF THE INFLUENZA-VIRUS HEMAGGLUTININ - INTERACTION OF HA2 N-TERMINAL PEPTIDES WITH PHOSPHOLIPID-VESICLES [J].
RAFALSKI, M ;
ORTIZ, A ;
ROCKWELL, A ;
VANGINKEL, LC ;
LEAR, JD ;
DEGRADO, WF ;
WILSCHUT, J .
BIOCHEMISTRY, 1991, 30 (42) :10211-10220
[38]   Conformational transitions of membrane-bound HIV-1 fusion peptide [J].
Sáez-Cirión, A ;
Nieva, JL .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1564 (01) :57-65
[39]   REQUIREMENT OF N-TERMINAL AMINO-ACID-RESIDUES OF GP41 FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-MEDIATED CELL-FUSION [J].
SCHAAL, H ;
KLEIN, M ;
GEHRMANN, P ;
ADAMS, O ;
SCHEID, A .
JOURNAL OF VIROLOGY, 1995, 69 (06) :3308-3314
[40]   Development of HIV fusion inhibitors [J].
Schneider, SE ;
Bray, BL ;
Mader, CJ ;
Friedrich, PE ;
Anderson, MW ;
Taylor, TS ;
Boshernitzan, N ;
Niemi, TE ;
Fulcher, BC ;
Whight, SR ;
White, JM ;
Greene, RJ ;
Stoltenberg, LE ;
Lichty, M .
JOURNAL OF PEPTIDE SCIENCE, 2005, 11 (11) :744-753